搜索筛选:
搜索耗时0.0862秒,为你在为你在102,285,761篇论文里面共找到 7 篇相符的论文内容
发布年度:
Secalonic acid D reduced the percentage of side populations by down-regulating the expression of ABC
[会议论文] 作者：Ya-peng Hu,Li-wu Fu,
来源：2013医学前沿论坛暨第十三届全国肿瘤药理与化疗学术会议 年份：2013
...
Secalonic acid D reduced the percentage of side populations by down-regulating the expression of ABC
[会议论文] 作者：Ya-peng Hu,Li-wu Fu,
来源：2013医学前沿论坛暨第十三届全国肿瘤药理与化疗学术会议 年份：2013
Background:The side population cells characterized by the ability to transport Hoechst 33342 out of cells have been identified as cancer stem-like cells.ABCG2 is found to confer the side population (S...
[期刊论文] 作者：Arshad Ali, Ya-Peng Hu, Mudassar Sabir, Taotao Sui,
来源：Science China(Physics,Mechanics 年份：2023
We revisit the vital issue of gauge dependence in the scalar-induced secondary gravitational waves（SIGWs）, focusing on the radiation domination（RD） and matter domination（MD） eras. The energy density s...
,Electrical bistable devices using composites of zinc sulfide nanoparticles and poly-(N-vinylcarbazo
[期刊论文] 作者：Cao Ya-Peng,Hu Yu-Feng,Li Jian-Tao,Ye Hai-Hang,Lü Long-Feng,Ning Yu,Lu Qi-Peng,
来源：中国物理B（英文版） 年份：2015
...
Lapatinib antagonizes multidrug resistance protein 1-mediated multidrug resistance by inhibiting its
[会议论文] 作者：Shaolin Ma,Ya-peng Hu,Fang Wang,Zhen-cong Huang,Yi-fan Chen,Xiao-kun Wang,Li-wu Fu,
来源：第八届中国肿瘤学术大会暨抗癌药物专业委员会中青年论坛 年份：2014
...
Lapatinib antagonizes multidrug resistance protein 1-mediated multidrug resistance by inhibiting its
[会议论文] 作者：Shaolin Ma,Ya-peng Hu,Fang Wang,Zhen-cong Huang,Yi-fan Chen,Xiao-kun Wang,Li-wu Fu,
来源：第八届中国肿瘤学术大会暨抗癌药物专业委员会中青年论坛 年份：2014
Objective: Lapatinib, which is used in the treatment with advanced or metastatic breast cancer overexpressing human epidermal receptor 2 (HER2), is an inhibitor of the tyrosine kinase EGFR (ErbB1) and...
Lapatinib antagonizes multidrug resistance-associated protein 1 mediated multidrug resistance by inh
[会议论文] 作者：Shao-lin Ma,Ya-peng Hu,Fang Wang,Zhen-cong Huang,Yi-fan Chen,Xiao-kun Wang,Li-wu Fu,
来源：2014医学科学前沿暨第三届个体化治疗与抗肿瘤药物研究新趋向研讨会 年份：2014
Lapatinib, a tyrosine kinase inhibitor (TKI), is used in the treatment of advanced or metastatic breast cancer overexpressing human epidermal receptor 2 (HER2).Lapatinib can modulate the function of A...
相关搜索：
